Today’s AI Top Pick: PODD
7/16/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PODD price forecast →
Insulet (PODD) is the cleanest confluence of a deep-drawdown reset with multi-timeframe forecasts turning up hard. On the weekly it is still down -35.12% from the 21-bar high and sitting at just 14.81% of range — this is emphatically not a chased breakout — yet the daily has already inflected higher with recent_21bar_pct +8.34%, and forecasts across 4h (+19.37 mid / +52.72 long), 1d (+50.65 mid / +62.44 long) and 1wk (+33.80 mid / +52.31 long) all point sharply higher. Bullish probability is 1.0 and near-term bullish is 1.0. That is textbook multi-timeframe alignment. The fundamentals underwrite the tape. FwdPe 19.78 is reasonable for a Healthcare growth name with ROE 23%, profit margin 10.4%, salesYoY +31.93% and epsNextY +24.34%. Analyst recom sits at 1.44 (strong-buy tilt) with targetUpsidePct +47.5%. Fundamental_score is 8, tied for the highest in the pool. The July 16 ChartMill note explicitly frames PODD as 'A Quality Affordable Growth Stock With Strong Earnings Momentum' and the July 14 Insulet-Calm partnership plus a supportive Global Blood Glucose Monitoring market backdrop are small but clean positive catalysts — no legal, dilution or short-seller landmines. Why TODAY vs. waiting: the setup is a pullback-to-reset that has already turned. The 1h forecast is modestly red (-8.88/-5.17) which is a tactical caution but not a thesis-breaker; it argues for scaling in rather than skipping. Contrast with FUTU (equally strong forecasts but a live DOJ probe and class actions dated July 3 — that alone disqualifies it as the #1 pick), HSAI (pe 283, still stretched despite the 8-for-1 split catalyst), ORCL (RSI 30, oversold buy, but 1wk forecast is still negative -0.68 to -5.13), and TMDX/CELH (high short floats 23% and 20% — squeeze fuel but also fragile). PODD delivers the same magnitude of forecast upside without the tape or headline landmines. Bottom line: fundamentals-approved growth compounder, -35% weekly drawdown, forecast momentum inflecting positive across all 4 timeframes, clean news backdrop, top-tier fundamental score. Best risk-adjusted entry in the pool today.
- 1h forecasts are -8.88% short / -5.17% mid — expect an intraday shake before the trend resumes; do not chase up
- -45.07% 1-year perf and -43.96% YTD means overhead supply is heavy; each rally will meet trapped longs
- shortFloat 7.04% is moderate but healthcare-device names are earnings-binary; PODD reports could gap either way
- debtEq 0.73 and instOwn 104.9% (crowded ownership) — any hedge fund rotation out of medtech growth is a headwind
- 1wk drawdown -35% means the weekly downtrend is not yet confirmed broken; needs a weekly close above the 21-bar midpoint
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PODD | BUY NOW | 8.7 | Deep -35% weekly reset with 4h/1d/1wk forecasts all +19% to +62% and fundamental_score 8 — best multi-timeframe alignment in the pool. |
| 2 | HSAI | BUY NOW | 8.1 | 8-for-1 split catalyst plus 1d/4h forecasts +45-50% from weekly range bottom 8.56%. |
| 3 | ORCL | BUY PULLBACK | 7.7 | RSI 30, ROE 54%, targetUpside 92%, daily forecast +48% long — but 1wk forecast still red, wait for weekly turn. |
| 4 | TMDX | BUY NOW | 7.4 | 1d forecast +51/+58, weekly -47% drawdown; 23.57% short float adds squeeze fuel. |
| 5 | TIGR | BUY NOW | 7.2 | FwdPe 6.02, epsNextY +63.97%, 1d forecasts +30/+90/+93 from weekly pos 9.94%. |
| 6 | CELH | BUY NOW | 7.0 | SalesYoY +123%, 1d forecast +30/+48/+54, undervalued narrative and 20% short interest for squeeze. |
| 7 | BILI | BUY PULLBACK | 6.8 | Strong 1d forecasts +16/+39/+32 but at 100% of daily range — chase risk; wait for pullback. |
| 8 | CHWY | BUY PULLBACK | 6.7 | 1d forecast +38/+49, ROE 63.82%, but daily pos 96.56% — buy the dip not the print. |
| 9 | CALX | BUY NOW | 6.6 | PEG 0.42, epsNextY +40.78%, 1d forecasts +30/+34, earnings next week is the catalyst. |
| 10 | MLCO | BUY NOW | 6.4 | PEG 0.33, fwdPe 7.64, 1wk forecasts +19/+42/+51 from range position 0% — deepest value. |
| 11 | MNDY | BUY PULLBACK | 6.3 | Weekly pos 86% but 1d forecast +54% mid; gross margin 89%, wait for entry. |
| 12 | SRAD | BUY NOW | 6.2 | PEG 0.48, epsNextY +69.71%, 1d forecasts +35/+34, JPM PT bumped to $17. |
| 13 | STEP | BUY NOW | 6.1 | SalesYoY +69.89%, 1d/4h forecasts +23% consistently, recom 1.38 with dual analyst reiterations. |
| 14 | RBBN | BUY NOW | 6.0 | RSI 40, 1d forecasts +18/+38/+38 from daily pos 12% — small-cap turnaround setup. |
| 15 | KKR | BUY PULLBACK | 5.9 | At 100% of daily and 91% of weekly range — great franchise, wrong entry point today. |
| 16 | NOW | BUY PULLBACK | 5.8 | 1d/1wk forecasts +30/+22 long but 1h/4h forecasts red — needs a pullback into $100. |
| 17 | ARES | BUY PULLBACK | 5.7 | Whitestone REIT deal closed, but 1wk forecasts -7 to -10% and near range highs. |
| 18 | GRAB | WAIT | 5.6 | CEO sold 400k shares — near-term overhang despite +18% mid daily forecast. |
| 19 | SE | WAIT | 5.4 | RSI 71.7, at 100% of daily and weekly range, insider selling — momentum but no margin of safety. |
| 20 | FICO | BUY PULLBACK | 5.4 | Solid setup with earnings date announced but 1wk forecasts -7 to -14%, ps 12.4 stretched. |
| 21 | SPOT | WAIT | 5.3 | 1wk forecast -12 to -28%; premium valuation ps 4.91, wait for reset. |
| 22 | ONON | WAIT | 5.2 | JPM Overweight resumption is nice but near_term_bullish 0 and 1h forecast red. |
| 23 | TOST | WAIT | 4.9 | RSI 69.5, 100% range on 4h/1d/1wk, and 1h/4h forecasts -12 to -22%. Overheated. |
| 24 | BESS | WAIT | 4.9 | Micro-cap; strong 1d/1wk forecasts but no revenue data and instOwn 11% — lottery ticket. |
| 25 | FUTU | AVOID | 4.8 | Forecasts scream buy but active DOJ probe + class actions (July 3) — thesis broken by headline risk. |
| 26 | PGY | WAIT | 4.6 | 1wk forecast -22/-52/-50 undercuts everything; at 100% weekly range. |
| 27 | GOTU | WAIT | 4.5 | EpsNextY +1145% is math artifact; negative operMargin -8.27% and profitMargin -6.41%. |
| 28 | WING | WAIT | 4.3 | RSI 39.76 with 'why shares are falling' headline; earnings-driven weakness, no confirmation. |
| 29 | SDA | AVOID | 3.9 | $85M market cap, pe 465, instOwn 0.31%, profitMargin 0.04% — not investable. |
| 30 | JBI | AVOID | 3.7 | SalesYoY -2.54%, StockStory sell coverage, no positive catalysts to counter the deterioration. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord